These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 7935849

  • 1. Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.
    Sarre S, De Klippel N, Herregodts P, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):15-21. PubMed ID: 7935849
    [Abstract] [Full Text] [Related]

  • 2. Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.
    Izurieta-Sánchez P, Sarre S, Ebinger G, Michotte Y.
    Eur J Pharmacol; 1998 Jul 17; 353(1):33-42. PubMed ID: 9721037
    [Abstract] [Full Text] [Related]

  • 3. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S, Herregodts P, Deleu D, Devrieze A, De Klippel N, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep 17; 346(3):277-85. PubMed ID: 1407014
    [Abstract] [Full Text] [Related]

  • 4. Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
    Dethy S, Laute MA, Damhaut P, Goldman S.
    J Neural Transm (Vienna); 1999 Sep 17; 106(2):145-58. PubMed ID: 10226935
    [Abstract] [Full Text] [Related]

  • 5. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep 17; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 6. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW, Abercrombie ED.
    J Neurochem; 1999 Apr 17; 72(4):1516-22. PubMed ID: 10098856
    [Abstract] [Full Text] [Related]

  • 7. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 17; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 8. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S, Lanza M, Makovec F, Artusi R, Caselli G, Michotte Y.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):297-305. PubMed ID: 18342306
    [Abstract] [Full Text] [Related]

  • 9. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K, Tanaka H, Maeda T, Tomiyama M, Suda T, Matsunaga M.
    J Neurochem; 2000 Jan 28; 74(1):263-9. PubMed ID: 10617128
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of L-DOPA biotransformation during repeated L-DOPA infusion into the striatum in freely-moving young and old rats.
    Shui H, Peng Y, Wu R, Tsai Y.
    Brain Res Dev Brain Res; 2000 May 11; 121(1):123-31. PubMed ID: 10837901
    [Abstract] [Full Text] [Related]

  • 11. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA, Rose S, Jenner P.
    Eur J Neurosci; 2001 Jan 11; 13(1):162-70. PubMed ID: 11135014
    [Abstract] [Full Text] [Related]

  • 12. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
    Gołembiowska K, Dziubina A.
    Brain Res; 2004 Feb 20; 998(2):208-17. PubMed ID: 14751592
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
    Sarre S, Vandeneede D, Ebinger G, Michotte Y.
    J Neurochem; 1998 Apr 20; 70(4):1730-9. PubMed ID: 9523592
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H, Kannari K, Yamato H, Arai A, Matsunaga M.
    Tohoku J Exp Med; 2003 Mar 20; 199(3):149-59. PubMed ID: 12703659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.